These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7025257)

  • 21. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of different antihypertensive therapies on plasma lipids.
    Gomez G
    Practitioner; 1982 May; 226(1367):985-91. PubMed ID: 7100090
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total cholesterol, high density lipoprotein-cholesterol and triglycerides after a standardized high-fat meal.
    Thelle DS; Cramp DG; Patel I; Walker M; Marr JW; Shaper AG
    Hum Nutr Clin Nutr; 1982; 36(6):469-74. PubMed ID: 7161142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H; Kanto J; Pakkanen A; Wendelin H
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW; Khokhar AM; Flax JS
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 10 weeks endurance training on the concentration of lipids and lipoproteins as well as on the composition of high-density lipoproteins in blood serum.
    Schriewer H; Günnewig V; Assmann G
    Int J Sports Med; 1983 May; 4(2):109-15. PubMed ID: 6874171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of labetalol on lipid and carbohydrates metabolism.
    Pagnan A; Pessina AC; Hlede M; Zanetti G; Dal Palu' C
    Pharmacol Res Commun; 1979 Mar; 11(3):227-36. PubMed ID: 223175
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of oxprenolol and metoprolol on serum lipid concentration.
    Ferrara LA; Marotta T; Scilla A; Mastranzo P; Strazzullo P; Mancini M
    Eur J Clin Pharmacol; 1984; 26(3):331-4. PubMed ID: 6734694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxprenolol, methyldopa and lipids in diabetes mellitus.
    Benfield GF; Hunter KR
    Br J Clin Pharmacol; 1982 Feb; 13(2):219-22. PubMed ID: 7037030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the beta-receptor antagonists propranolol, oxprenolol and labetalol on human vascular smooth-muscle contraction.
    Moulds RF; Jauernig RA; Hobson JD; Shaw J
    Clin Sci Mol Med; 1978 Sep; 55(3):235-40. PubMed ID: 29741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.
    Frishman W; Halprin S
    Am Heart J; 1979 Nov; 98(5):660-5. PubMed ID: 386753
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress.
    Bachen EA; Muldoon MF; Matthews KA; Manuck SB
    Psychosom Med; 2002; 64(4):587-94. PubMed ID: 12140348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment with slow release oxprenolol alone, or in combination with other drugs: effects on blood pressure, lipoproteins and exercise performance.
    Simons LA; England JD; Balasubramaniam S; Viles L
    Aust N Z J Med; 1982 Dec; 12(6):612-6. PubMed ID: 6962709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of labetalol on the cardiovascular, hyperglycaemic and adrenocortical responses to surgery.
    Child CS
    Anaesthesia; 1984 Dec; 39(12):1192-6. PubMed ID: 6517247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labetalol and platelet function in pre-eclampsia.
    Walker JJ; Erwin L; Lang G; Prentice CR; Belch JJ; McLaren M; Forbes CD; Calder AA
    Lancet; 1982 Jul; 2(8292):279. PubMed ID: 6124708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.